Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Wu, Li Na ^a   Xue, Yi Jun ^b   Zhang, Li Jian ^a   Ma, Xue Mei ^b   Chen, Jin Feng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

CELF1 gene; Lung cancer; Proliferation

Indexed keywords

CELF1 PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CANCER TISSUE; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LENTIVIRINAE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDIATOR; PATHOPHYSIOLOGY; PROTEIN FUNCTION; VIRAL GENE DELIVERY SYSTEM;

EID: 84887538380     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-115     Document Type: Article

References (18)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA: Cancer J Clin 1999, 49(1):33-64. 31, 10.3322/canjclin.49.1.33, 10200776.
2. Caldon CE, Lee CS, Sutherland RL, Musgrove EA. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 2008, 27(1):126-138. 10.1038/sj.onc.1210622, 17599043.
3. Yang M, Yuan F, Li P, Chen Z, Chen A, Li S, Hu C. Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells. Mol Cancer 2012, 11:54. 10.1186/1476-4598-11-54, 3447665, 22888789.
4. Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res 2006, 66(4):2028-2037. 10.1158/0008-5472.CAN-04-4559, 16489002.
5. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. British J Cancer 1987, 55(5):513-516.
6. Timchenko NA, Welm AL, Lu X, Timchenko LT. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res 1999, 27(22):4517-4525. 10.1093/nar/27.22.4517, 148737, 10536163.
7. Chang ET, Donahue JM, Xiao L, Cui Y, Rao JN, Turner DJ, Twaddell WS, Wang JY, Battafarano RJ. The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability. Biochem J 2012, 446(1):113-123. 10.1042/BJ20120112, 22646166.
8. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, Von Hohenberg M, St Louis-Vlasova IA, Bohjanen PR. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 2010, 30(16):3970-3980. 10.1128/MCB.00624-10, 2916446, 20547756.
9. Zheng Y, Miskimins WK. CUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry site. RNA Biol 2011, 8(3):365-371. 10.4161/rna.8.3.14804, 3218506, 21508681.
10. Ward AJ, Rimer M, Killian JM, Dowling JJ, Cooper TA. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Gen 2010, 19(18):3614-3622. 10.1093/hmg/ddq277, 2928132, 20603324.
11. Kang S, Koh ES, Vinod SK, Jalaludin B. Cost analysis of lung cancer management in South Western Sydney. J Med Imaging Radiat Oncol 2012, 56(2):235-241. 10.1111/j.1754-9485.2012.02354.x, 22498199.
12. Benjamin D, Moroni C. mRNA stability and cancer: an emerging link?. Expert Opinion Biol Ther 2007, 7(10):1515-1529.
13. Cui YH, Xiao L, Rao JN, Zou T, Liu L, Chen Y, Turner DJ, Gorospe M, Wang JY. miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies. Mol Biol Cell 2012, 23(1):151-162. 10.1091/mbc.E11-05-0456, 3248894, 22072795.
14. Vlasova-St Louis I, Bohjanen PR. Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1. Curr Opin Gen Dev 2011, 21(4):444-451.
15. Jones K, Timchenko L, Timchenko NA. The role of CUGBP1 in age-dependent changes of liver functions. Ageing Res Rev 2012, 11(4):442-449. 10.1016/j.arr.2012.02.007, 3610417, 22446383.
16. Devi GR. siRNA-based approaches in cancer therapy. Cancer Gene Ther 2006, 13(9):819-829. 10.1038/sj.cgt.7700931, 16424918.
17. Jiao W, Zhao J, Wang M, Wang Y, Luo Y, Zhao Y, Tang D, Shen Y. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer. Clin Transl Oncol 2013, 15(10):789-795. 10.1007/s12094-013-1005-5, 23359188.
18. Talwar S, Balasubramanian S, Sundaramurthy S, House R, Wilusz CJ, Kuppuswamy D, D'Silva N, Gillespie MB, Hill EG, Palanisamy V. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol 2013, 10(2):277-286. 10.4161/rna.23315, 3594286, 23324604.